Finance

Beta
Lists
Q2 2026 earnings • released • EPS beat +2,61% • Revenue beat +0,61%
See results
ABTT34:BVMF
Abbott Laboratories BDR
R$43,12
+1,60%
(+0,68) 1D
20 ກ.ລ., 15 ໂມງ 55 ນາທີ 06 ວິນາທີ GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for ABTT34...
Open
R$42,68
High
R$43,36
Low
R$42,68
Mkt. cap
໑໗໗,໑໘ ຕື້
Avg. vol.
໗໕໔,໐໐
Volume
໒໔໖,໐໐
52-wk high
R$60,89
52-wk low
R$33,35
Shares outstanding
໑,໗໔ ຕື້
No. of employees
໑໑໕ ພັນ
Open
R$42,68
High
R$43,36
Low
R$42,68
Mkt. cap
໑໗໗,໑໘ ຕື້
Avg. vol.
໗໕໔,໐໐
Volume
໒໔໖,໐໐
52-wk high
R$60,89
52-wk low
R$33,35
Shares outstanding
໑,໗໔ ຕື້
No. of employees
໑໑໕ ພັນ
News stories
From sources across the web
Profile
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices. Abbott operates in over 160 countries and sources from at least 62 suppliers worldwide. Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. The company is ranked 107th on the Fortune 500 and 144th on the Forbes Global 2000. Wikipedia
About Abbott Laboratories BDR
CEORobert B. Ford
Employees115 ພັນ
Founded1888
Headquartersຊິຄາໂກ, ອິລິນອຍ, ສະຫະລັດ
SectorMedical device
Websiteabbott.com
Last report
16 ກ.ລ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
US$1,31 / US$1,28
+2,61%beat
Revenue / Est. (USD)
໑໒,໕໙ ຕື້ / ໑໒,໕໒ ຕື້
+0,61%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
11,37 ຕື້
11,46 ຕື້
11,16 ຕື້
12,59 ຕື້
Cost of goods sold
5,08 ຕື້
4,91 ຕື້
4,89 ຕື້
5,29 ຕື້
Cost of revenue
5,08 ຕື້
4,91 ຕື້
4,89 ຕື້
5,29 ຕື້
Research and development expenses
766,00 ລ້ານ
720,00 ລ້ານ
767,00 ລ້ານ
882,00 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,90 ຕື້
2,93 ຕື້
3,58 ຕື້
3,98 ຕື້
Operating expense
4,09 ຕື້
4,07 ຕື້
4,77 ຕື້
5,52 ຕື້
Total operating expenses
9,16 ຕື້
8,98 ຕື້
9,66 ຕື້
10,81 ຕື້
Operating income
2,20 ຕື້
2,48 ຕື້
1,50 ຕື້
1,78 ຕື້
Other non operating income
2,00 ລ້ານ
-15,00 ລ້ານ
-
134,00 ລ້ານ
EBT including unusual items
2,18 ຕື້
2,36 ຕື້
1,45 ຕື້
1,52 ຕື້
EBT excluding unusual items
2,18 ຕື້
2,44 ຕື້
1,45 ຕື້
1,61 ຕື້
Income tax expense
536,00 ລ້ານ
582,00 ລ້ານ
372,00 ລ້ານ
596,00 ລ້ານ
Effective tax rate
24,59%
24,68%
25,67%
39,11%
Other operating expenses
-
-
-
-
Net income
1,64 ຕື້
1,78 ຕື້
1,08 ຕື້
928,00 ລ້ານ
Net profit margin
14,46%
15,50%
9,65%
7,37%
Earnings per share
1,30
1,50
1,15
1,31
Interest and investment income
77,00 ລ້ານ
78,00 ລ້ານ
106,00 ລ້ານ
-
Interest expense
-121,00 ລ້ານ
-120,00 ລ້ານ
-174,00 ລ້ານ
-299,00 ລ້ານ
Net interest expenses
-44,00 ລ້ານ
-42,00 ລ້ານ
-68,00 ລ້ານ
-299,00 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
3,00 ຕື້
3,27 ຕື້
2,31 ຕື້
2,58 ຕື້
Gain or loss from assets sale
-
65,00 ລ້ານ
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer